FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis

Molecular Endocrinology

Volumn 27, Issue 1, 2013, Pages 50-62

  Zaballos, Miguel A ^a   Santisteban, Pilar ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; SOMATOMEDIN C; THYROTROPIN; TRANSCRIPTION FACTOR FKHR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CELL; THYROID FOLLICLE CELL; THYROID TUMORIGENESIS; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CARCINOMA; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN;

RATTUS;

EID: 84871803197     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1032     Document Type: Article

References (43)

1. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656
2. Medina DL, Santisteban P 2000 Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Eur J Endocrinol 143:161-178
3. Santisteban P, Kohn LD, Di Lauro R 1987 Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells. J Biol Chem 262: 4048-4052
4. Zarrilli R, Formisano S, Di Jeso B 1990 Hormonal regulation of thyroid peroxidase in normal and transformed rat thyroid cells. Mol Endocrinol 4:39-45
5. García B, Santisteban P 2002 PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression. Mol Endocrinol 16:342-352
6. Muca C, Vallar L 1994 Expression of mutationally activated Gas stimulates growth and differentiation of thyroid FRTL5 cells. Oncogene 9:3647-3653
7. Blancquaert S, Wang L, Paternot S, Coulonval K, Dumont JE, Harris TE, Roger PP 2010 CAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mito-genesis and activation of CDK4. Mol Endocrinol 24:1453-1468
8. Krause K, Boisnard A, Ihling C, Ludgate M, Eszlinger M, Krohn K, Sinz A, Fuhrer D 2012 Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid. Int J Biochem Cell Biol 44:290-301
9. Liu YY, Zhang X, Ringel MD, Jhiang SM 2012 Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells. Endocr Relat Cancer 19: 291-304
10. Yamanaka D, Akama T, Fukushima T, Nedachi T, Kawasaki C, Chida K, Minami S, Suzuki K, Hakuno F, Takahashi S 2012 Phos- phatidylinositol 3-kinase-binding protein, PI3KAP/XB130, is required for cAMP-induced amplification of IGF mitogenic activity in FRTL-5 thyroid cells. Mol Endocrinol 26:1043-1055
11. Bhaskar PT, Hay N 2007 The two TORCs and Akt. Dev Cell 12:487-502
12. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM 2005 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101
13. Ciampolillo A, De Tullio C, Giorgino F 2005 The IGF-I/IGF-I receptor pathway: Implications in the pathophysiology of thyroid cancer. Curr Med Chem 12:2881-2891
14. Li X, Lu S, Miyagi E, Katoh R, Kawaoi A 1999 Thyrotropin prevents apoptosis by promoting cell adhesion and cell cycle progression in FRTL-5 cells. Endocrinology 140:5962-5970
15. Saavedra AP, Tsygankova OM, Prendergast GV, Dworet JH, Cheng G, Meinkoth JL 2002 Role of cAMP, PKA and Rap1A in thyroid follicular cell survival. Oncogene 21:778-788
16. Accili D, Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426
17. Dansen TB, Burgering BM 2008 Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol 18:421-429
18. Calnan DR, Brunet A 2008 The Foxo code. Oncogene 27:2276-2288
19. Hosaka T, Biggs 3rd WH, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC 2004 Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 101:2975-2980
20. Huang H, Tindall DJ 2011 Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim Biophys Acta 1813:1961-1964
21. Paes JE, Ringel MD 2008 Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia. Endocrinol Metab Clin North Am 37:375-387, viii-ix
22. Guigon CJ, Zhao L, Willingham MC, Cheng SY 2009 PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene 28:509-517
23. Shinohara M, Chung YJ, Saji M, Ringel MD 2007 AKT in thyroid tumorigenesis and progression. Endocrinology 148:942-947
24. Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H, Fuhrer D 2009 FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer 16:189-199
25. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vec-chio G 1987 One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7:3365-3370
26. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA 77:3455-3459
27. Costamagna E, García B, Santisteban P 2004 The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-/3 repression of the sodium/iodide symporter gene. J Biol Chem 279:3439-3446
28. Mitsutake N, Knauf JA, Mitsutake S, Mesa Jr C, Zhang L, Fagin JA 2005 Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res 65:2465-2473
29. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Hau-gen BR 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting incell line redundancy and misidentification. J Clin Endocrinol Metab 93:4331-4341
30. Bradford MM 1976 A rapid and sensitive method for the quanti-tation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
31. Aoki M, Jiang H, Vogt PK 2004 Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci USA 101:13613-13617
32. Büch TR, Biebermann H, Kalwa H, Pinkenburg O, Hager D, Barth H, Aktories K, Breit A, Gudermann T 2008 G13-dependent activation of MAPK by thyrotropin. J Biol Chem 283:20330-20341
33. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, Iwashita S, Kako K, Kishi T, Kasuya Y, Fukamizu A 2007 Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 19:519-527
34. Medema RH, Kops GJ, Bos JL, Burgering BM 2000 AFX-like Fork-head transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782-787
35. Biggs 3rd WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC 1999 Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96:7421-7426
36. Liu Z, Hou P, Ji M, Guan H, Studeman K, Jensen K, Vasko V, El-Naggar AK, Xing M 2008 Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab 93:3106-3116
37. Gross DN, van den Heuvel AP, Birnbaum MJ 2008 The role of FoxO in the regulation of metabolism. Oncogene 27:2320-2336
38. Huang H, Tindall DJ 2006 FOXO factors: a matter of life and death. Future Oncol 2:83-89
39. Kousteni S 2011 FoxO1: a molecule for all seasons. J Bone Miner Res 26:912-917
40. Storz P 2011 Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid Redox Signal 14:593- 605
41. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR 2000 Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20:8969-8982
42. van der Vos KE, Coffer PJ 2011 The extending network of FOXO transcriptional target genes. Antioxid Redox Signal 14:579-592
43. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR 2002 A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2:81-91